Navigation Links
HyperMu Transposon from EPICENTRE Biotechnologies

ProductsHyperMu Transposon from EPICENTRE Biotechnologies
Company EPICENTRE Biotechnologies
Item HyperMu Transposon
Price $165.00
Description Component of HyperMu™ Insertion Kit
Info EPICENTRE BiotechnologiesEPICENTRE Biotechnologies
726 Post Road
Madison, WI 53713
USA
Customer Service: 800-284-8474
Tech Support: 800-284-8474
Fax Number: 608-442-6114
Web Site: http://www.epibio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GELase LMP Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
2. GELase LMP Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
3. Vaccinia DNA Topoisomerase I from EPICENTRE Biotechnologies
4. Vaccinia DNA Topoisomerase I from EPICENTRE Biotechnologies
5. GELase LMT Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
6. GELase LMT Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
7. GELase LMT Agarose Gel-Digesting Preparation from EPICENTRE Biotechnologies
8. EZ-Tn5 Transposase from EPICENTRE Biotechnologies
9. DNA Exonuclease III , E. coli from EPICENTRE Biotechnologies
10. DNA Polymerase I, E. coli from EPICENTRE Biotechnologies
11. T4 Polynucleotide Kinase from EPICENTRE Biotechnologies
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3